Yiying Li

794 citations
49 papers · 536 indexed · h-index 14
Topics
Pulmonary Hypertension Research and Treatments (6 papers)Cancer-related molecular mechanisms research (5 papers)RNA modifications and cancer (4 papers)
Partner nations
ChinaTaiwanJapan

In The Last Decade

Yiying Li

45 papers receiving 530 citations

Peers

Yiying Li
Comparison fields: 5 of 113
  • Molecular Biology 196
  • Cancer Research 104
  • Pulmonary and Respiratory Medicine 98
  • Oncology 76
  • Cognitive Neuroscience 45
Replace Xiaodan Yu with:
Xiaodan Yu China
Xiaoli Chen China
Anne Hoffmann Germany
David Rotter United States
Claus Bischoff Denmark
Min Tang China
Kwangmi Ahn United States
Xuejiao Chen China
M. Reza Sailani United States
Honghui Li China
Yiying Li relative to Xiaodan Yu China Xiaodan Yu's profile →
Citations per field
00.5×1.5×2.0×
Xiaodan Yu · 1×
Citations per year

Countries citing papers authored by Yiying Li

Since Specialization
Citations

This map shows the geographic impact of Yiying Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiying Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiying Li more than expected).

Fields of papers citing papers by Yiying Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiying Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiying Li. The network helps show where Yiying Li may publish in the future.

Co-authorship network of co-authors of Yiying Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yiying Li. A scholar is included among the top collaborators of Yiying Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiying Li. Yiying Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 5
4 19
5 0
6 16
7 13
8 2
9 26
10 29
11 17
12 42
13 9
14 28
15 0
16 1
17 8
18 14
19 54
20
Selection of attenuated muscovy duck reovirus vaccine strain
3

About Yiying Li

Yiying Li is a scholar working on Cancer Research, Applied Microbiology and Biotechnology and Immunology, having authored 49 papers that have together received 536 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (6 papers), Cancer-related molecular mechanisms research (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (104 citations), Endocrine and Autonomic Systems (34 citations) and Biological Psychiatry (8 citations). Yiying Li has collaborated with scholars based in China, Taiwan and Japan. Frequent co-authors include Jing Chen, June Liu, Mulan Wang, Chia‐Lin Chang, Daling Zhu, Meina Wu, Michael McAleer, Fang Zhou, Jin‐Shun Qi and Hua Jiang. Their work appears in journals such as Angewandte Chemie International Edition, Circulation and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026